icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Seattle, Washington
Feb 19-22 2023
Back grey_arrow_rt.gif
 
 
 
REMDESIVIR REDUCES MORTALITY IN
IMMUNOCOMPROMISED PATIENTS HOSPITALIZED FOR COVID-19
 
 
  CROI 2023 Feb 20-23
 
Essy Mozaffari1, Aastha Chandak2, Robert L Gottlieb3, Andre C Kalil4, Stephanie H Read5, Heng Jiang6, Mel Chiang7, EunYoung Lee1, Rikisha Gupta1, Mark Thrun1, Chidinma Chima-Melton8 1Gilead Sciences, Foster City, CA; 2Certara, New York, NY; 3Baylor Scott and White Research Institute, Dallas, TX; 4University of Nebraska Medical Center, Omaha, NE; 5Certara, London, UK; 6Certara, Paris, France; 7Gilead Sciences, Taipei, Taiwan; 8UCLA Health, Torrance, CA

0322231

0322232

0322233

0322234

0322235

0322236